Interestingly nineteen patients underwent static and dynamic 68Ga-FAPI-46 PET in addition to FDG in order to characterise lepidic lung cancer as a known FDG–negative target, and FAP IHC of 24 tissue sections of lepidic lung cancer surprisingly revealed strong FAP positivity in all specimens. This evidence concerns the gene FAP and lung carcinoma.